A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial
Daisuke Tomizawa(National Center For Child Health and Development), Katsuyoshi Koh(Saitama Children's Medical Center), Yuhki Koga(Kyushu University), Keizo Horibe(National Hospital Organization), Akihiro Iguchi(Hokkaido University), Takao Deguchi(Mie University), Masashi Sanada(Nagoya Medical Center), Atsushi Manabe(St. Luke's International Hospital), Takako Miyamura(The University of Osaka), Yuki Arakawa(Saitama Children's Medical Center), Yoshihiro Takahashi, Eiichi Ishii(Japan Medical Association), Masahiro Hirayama(Mie University), Masami Haba(Chiba Institute of Science), Tomohiko Taki(Kyorin University), Tomoyuki Watanabe(Aichi Gakuin University), Akiko Saito(Nagoya University Hospital), Toshinori Hori(Aichi Medical University), Toshihiko Imamura(Kyoto Prefectural University of Medicine), Shigeru Ohmori(Shinshu University Hospital), Atsushi Ogawa(Niigata Cancer Center Hospital)
Cited by 102
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity
|Nature Genetics|2016|473
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383